Oligomerized Amyloid Beta, p-tau217, and APOE Genotyping in Blood*

฿11,120.00

Combines two Alzheimer’s-related blood biomarkers with APOE genotyping, which provides genetic-risk information.

Blood
15 min at lab
Results: 15 days

Typical Use

Used in clinician-led assessment of cognitive impairment and may help inform discussions about genetic susceptibility and the risk of ARIA with certain anti-amyloid treatments.

Preparation

Wear clothing that allows easy access to your arm
Arrive well-hydrated
Continue regular medications unless advised otherwise by your doctor